Trial Profile
Phase II Testing of ADI-PEG in Hepatocellular Carcinoma
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Pegargiminase (Primary)
- Indications Liver cancer
- Focus Therapeutic Use
- 26 Aug 2005 New trial record.